Fibromyalgia Treatment Market Outlook:
Fibromyalgia Treatment Market size was over USD 3.2 billion in 2025 and is projected to reach USD 4.69 billion by 2035, witnessing around 3.9% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of fibromyalgia treatment is evaluated at USD 3.31 billion.
The growth of the market is primarily ascribed to the worldwide escalating load of chronic pain. Fibromyalgia, according to researchers, increases painful sensations by altering how the brain and spinal cord receive painful and non-painful impulses. As per the World Health Organization (WHO), nearly 1.71 billion people around the world have been suffering from musculoskeletal disorders.
Fibromyalgia, commonly known as fibromyalgia syndrome, is a severe neurologic condition that results in immense pain throughout the body. This condition affects people physically, intellectually, and socially and causes exhaustion, musculoskeletal pain, and localized discomfort. Furthermore, there are only a few drugs, such as milnacipran, and pregabalin which are prescribed for fibromyalgia treatment. Globally rising occurrence of musculoskeletal disorder is leading to increased chances of fibromyalgia. According to the National Fibromyalgia Association, fibromyalgia affects an estimated 10 million people in the United States.
